title: UGT2B17 gene deletion associated with an increase in bone mineral density similar to the effect of hormone replacement in postmenopausal women.
abstract: UGT2B17 is one of the most important enzymes for androgen metabolism. In addition, the UGT2B17 gene is one of the most commonly deleted regions of the human genome. The deletion was previously found associated with higher femoral bone density in men and women, and we replicated this association in a sample of postmenopausal who never used hormone therapy.
  
  
  BACKGROUND
  Deletion of the UGT2B17 gene was previously shown to be associated with a higher hip bone mineral density (BMD). Using a PCR assay, we tried to replicate the association among a large group of 2,379 women. We examined the effect of the deletion on femoral neck BMD and lumbar spine BMD according to the menopausal status and hormone replacement therapy (HRT).
  
  
  METHODS
  We used a high-throughput PCR assay to identify the gene and the deletion in a population of well-characterized women. Two additional polymorphisms, UGT2B28 deletion and UGT2B15 rs1902023 G > T were also investigated.
  
  
  RESULTS
  Only UGT2B17 deletion was associated with LS and FN BMD. Furthermore, the association was seen only among postmenopausal women who had never used hormone replacement as in the first reported association.
  
  
  CONCLUSIONS
  We confirmed the association between UGT2B17 deletion and a higher LS and FN BMD. In addition, we show that the association is observed among postmenopausal women who never used HRT consistent with the enzymatic function of UGT2B17. The analysis shows that those having one or two UGT2B17 alleles benefit from HRT, which is not the case for null carriers.
authors: Centre de Recherche de l'Hôpital St-François d'Assise du Centre hospitalier universitaire de Québec, 10 rue de l'Espinay, Québec G1L 3L5, Canada. sylvie.giroux@crsfa.ulaval.ca
authors: S
authors: S
authors: Giroux
authors: J
authors: J
authors: Bussières
authors: A
authors: A
authors: Bureau
authors: F
authors: F
authors: Rousseau
references: JAMA. 1989 Nov 24;262(20):2853-8
references: 2810620
references: Clin Rheumatol. 1991 Mar;10(1):49-53
references: 2065507
references: Clin Genet. 2000 Mar;57(3):161-9
references: 10782923
references: Menopause. 2003 Sep-Oct;10(5):412-9
references: 14501602
references: Bone. 2007 May;40(5):1299-307
references: 17307038
references: Physiol Rev. 2001 Jan;81(1):419-447
references: 11152762
references: Rev Fr Gynecol Obstet. 1995 May-Jun;90(5-6):263-4, 267-74
references: 7569587
references: Osteoporos Int. 2005 Dec;16(12):1849-56
references: 15997421
references: Osteoporos Int. 2009 May;20(5):771-7
references: 18766293
references: Genetics. 2000 Jun;155(2):945-59
references: 10835412
references: Endocrinology. 2001 Feb;142(2):778-87
references: 11159850
references: Urology. 2007 Aug;70(2):374-9
references: 17826523
references: Am J Hum Genet. 2008 Sep;83(3):337-46
references: 18760392
references: J Clin Endocrinol Metab. 2008 Jul;93(7):2500-6
references: 18334593
references: Osteoporos Int. 1995;5(4):276-80
references: 7492867
references: CMAJ. 2008 Jun 17;178(13):1660-8
references: 18559803
references: Osteoporos Int. 2008 Dec;19(12):1759-67
references: 18414963
references: Nat Genet. 2006 Jan;38(1):86-92
references: 16468122
references: Osteoporos Int. 2001;12(5):406-11
references: 11444090
references: Prostate. 2008 Apr 1;68(5):571-5
references: 18247404
references: Osteoporos Int. 2000;11(3):211-8
references: 10824236
references: Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):229-39
references: 20056642
references: Genomics. 2004 Oct;84(4):707-14
references: 15475248
references: Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1473-8
references: 16896035
references: Am J Hum Genet. 2008 Dec;83(6):663-74
references: 18992858
references: J Clin Endocrinol Metab. 2006 Feb;91(2):687-93
references: 16332934
references: J Bone Miner Res. 2007 Nov;22(11):1773-80
references: 17620052
references: J Bone Miner Res. 2006 Nov;21(11):1676-7
references: 17002565
references: Hum Mutat. 2009 Sep;30(9):1310-9
references: 19572376
references: Cancer Detect Prev. 2007;31(4):310-5
references: 17935910
references: Lancet. 2008 May 3;371(9623):1505-12
references: 18455228
references: J Clin Invest. 1987 Sep;80(3):706-10
references: 3624485
references: Osteoporos Int. 2011 Jun;22(6):1981-6
references: 20878390
references: J Clin Invest. 1973 Nov;52(11):2800-8
references: 4795916
references: Pharmacogenomics J. 2008 Apr;8(2):147-51
references: 17387331